Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-079923
Filing Date
2025-08-18
Accepted
2025-08-18 18:56:34
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2523790-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2523790-1_3seq1.xml 3 1531
  Complete submission text file 0001104659-25-079923.txt   3381
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Issuer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address D F18 TORRE RIO Y NEW YORK, MALECON CANCUN CENTRO BENITO JUAREZ Mexico 77500
Business Address
Sawyer Jason David (Reporting) CIK: 0002076325 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37853 | Film No.: 251229255